Role of novel adjuvants in specific active immunotherapy.
Cantrell
J L
JL
Ribi ImmunoChem Research, Inc. Hamilton, Montana 59840.
Finn
D J
DJ
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000818:Animals; D000942:Antigens, Bacterial / Q000008:administration & dosage / Q000627:therapeutic use*; D000951:Antigens, Neoplasm / Q000008:administration & dosage / Q000627:therapeutic use*; D005069:Evaluation Studies as Topic; D005260:Female; D007167:Immunotherapy; D008050:Lipid A / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D051379:Mice; D008809:Mice, Inbred C3H; D009368:Neoplasm Transplantation; D010051:Ovarian Neoplasms / Q000276:immunology / Q000628:therapy*; D011425:Propionibacterium acnes / Q000276:immunology; D013724:Teratoma / Q000276:immunology / Q000628:therapy*
D000276:Adjuvants, Immunologic; D000942:Antigens, Bacterial; D000951:Antigens, Neoplasm; D008050:Lipid A; C048436:monophosphoryl lipid A